These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1796916)

  • 41. Cardiovascular properties of LF 2.0254, a new potent vasoselective calcium channel blocker with a slow onset of action.
    Pruneau D; Roy F; Brown NL
    Fundam Clin Pharmacol; 1990; 4(2):223-43. PubMed ID: 2112508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac electrophysiological effects of a new dihydropyridine calcium antagonist (BBR 2160).
    Barbieri M; Masini I; Porciatti F; Cerbai E; Mugelli A
    Pharmacol Res; 1991 Jan; 23(1):87-94. PubMed ID: 2047363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular effects of elgodipine in conscious pigs with a normal coronary circulation and in conscious pigs with a healed myocardial infarction.
    van Woerkens LJ; Schotman SN; van der Giessen WJ; Verdouw PD
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):976-82. PubMed ID: 1714024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of (S)-nafenodone, a new antidepressant, in isolated guinea-pig atrial and ventricular muscle fibres.
    Pérez-Vizcaino F; Carrón R; Delpón E; Tamargo J
    Eur J Pharmacol; 1991 Jun; 199(1):43-50. PubMed ID: 1893926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of inhibition of calcium and potassium currents in guinea-pig cardiac contraction: comparison of beta-caryophyllene oxide, eugenol, and nifedipine.
    Sensch O; Vierling W; Brandt W; Reiter M
    Br J Pharmacol; 2000 Nov; 131(6):1089-96. PubMed ID: 11082115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres.
    Delgado C; Tamargo J; Tejerina T
    Br J Pharmacol; 1985 Dec; 86(4):765-75. PubMed ID: 4075015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.
    Shibata S; Satake N; Kodama I; Hester RK; Wang CG; Jino H; Hojo M; Tatsumi H; Gandhi V; Jones DJ
    Eur J Pharmacol; 1991 Oct; 203(3):337-44. PubMed ID: 1773820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular effects of KUR-1246, a new tetrahydronaphthalen derivative beta2-adrenoceptor agonist and a selective uterine relaxant.
    Furihata Y; Motokawa Y; Murata S; Kiguchi S; Kobayashi M; Murakami M; Kojima M; Yamamoto T
    Arzneimittelforschung; 2006; 56(1):18-24. PubMed ID: 16478001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
    Kuhn A; Carlsson J; Miketic S; Tebbe U
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818.
    Hattori Y; Fukao M; Houzen H; Qi F; Yamada Y; Kanno M
    Eur J Pharmacol; 1996 Apr; 301(1-3):99-106. PubMed ID: 8773452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Electrophysiological effects of KW-3049, a new dihydropyridine type Ca antagonist, on isolated rabbit hearts, sinus nodal tissues and guinea-pig ventricular muscles].
    Yoshitake I; Kubo K; Ikeda N; Kodama I; Toyama J; Yamada K
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):179-87. PubMed ID: 2431981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electropharmacological effects of a new dihydropyridine analog on isolated guinea pig papillary muscles and Purkinje fibers.
    Molyvdas PA; Sperelakis N
    J Cardiovasc Pharmacol; 1986; 8(3):449-58. PubMed ID: 2425157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats.
    Nakayama N; Ikezono K; Mori T; Yamashita S; Nakayama S; Tanaka Y; Hosokawa T; Minami Y; Masutani K; Yamamura Y
    J Cardiovasc Pharmacol; 1990 May; 15(5):836-44. PubMed ID: 1692946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro analysis of Ca-antagonistic effects of prenylamine as mechanisms for its cardiac actions.
    Hashimoto K; Nakagawa Y; Nabata H; Imai S
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):212-21. PubMed ID: 646520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
    Imagawa J; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of 4-aryl-2-methyl-5-nitro-1,4-dihydropyridine-3-carboxylates on the guinea pig papillary muscle and isolated human vena saphena magna that is used for coronary artery bypass grafting.
    Garaliene V; Barsys V; Mačys A; Vigante B; Krauze A
    Eur J Med Chem; 2011 Sep; 46(9):4441-7. PubMed ID: 21802798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro effects of the new calcium antagonist lacidipine.
    Kawada T; Sun HT; Nakazawa M; Imai S
    Jpn J Pharmacol; 1993 Jul; 62(3):289-96. PubMed ID: 8411776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac electrophysiologic effects of a new calcium antagonist, lacidipine.
    Cerbai E; DeBonfioli Cavalcabó P; Masini I; Visentin S; Giotti A; Mugelli A
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):604-9. PubMed ID: 1691391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular effects of NPK-1886, a new dihydropyridine compound with calcium entry blocking activity.
    Nagura J; Murayama B; Harada N; Suzuki K; Miyano T; Yajima M; Takeya K
    Jpn J Pharmacol; 1986 Mar; 40(3):399-409. PubMed ID: 3712868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary vasodilatory action of elgodipine in coronary artery disease.
    Suryapranata H; Maas A; MacLeod DC; de Feyter PJ; Verdouw PD; Serruys PW
    Am J Cardiol; 1992 May; 69(14):1171-7. PubMed ID: 1575187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.